StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) stock

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.54−0.02 (-1.28%)

Close on Nov 18, 2026Market cap $4.66MP/E –Yield –

Intelligent Bio Solutions operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Intelligent Bio Solutions's operating income for the twelve months ending Jun 30, 2026 was -$12.61M. For fiscal 2026 it was -$12.61M. The highest annual figure on record is -$2.86M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$12.61M–
FY2025Jun 30, 2025-$10.68M–
FY2024Jun 30, 2024-$10.28M–
FY2023Jun 30, 2023-$12.60M–
FY2022Jun 30, 2022-$8.34M–
FY2021Jun 30, 2021-$5.57M–
FY2020Jun 30, 2020-$2.86M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$3.97M–
Q3 FY2026CQ1 2026Mar 31, 2026-$2.95M–
Q2 FY2026CQ4 2025Dec 31, 2025-$2.64M–
Q1 FY2026CQ3 2025Sep 30, 2025-$3.00M–
Q4 FY2025CQ2 2025Jun 30, 2025-$3.11M–
Q3 FY2025CQ1 2025Mar 31, 2025-$2.56M–
Q2 FY2025CQ4 2024Dec 31, 2024-$2.26M–
Q1 FY2025CQ3 2024Sep 30, 2024-$2.73M–
Q4 FY2024CQ2 2024Jun 30, 2024-$2.81M–
Q3 FY2024CQ1 2024Mar 31, 2024-$2.95M–
Q2 FY2024CQ4 2023Dec 31, 2023-$1.99M–
Q1 FY2024CQ3 2023Sep 30, 2023-$2.53M–
Q4 FY2023CQ2 2023Jun 30, 2023-$2.70M–
Q3 FY2023CQ1 2023Mar 31, 2023-$6.54M–
Q2 FY2023CQ4 2022Dec 31, 2022-$2.13M–
Q1 FY2023CQ3 2022Sep 30, 2022-$1.22M–
Q4 FY2022CQ2 2022Jun 30, 2022-$2.09M–
Q3 FY2022CQ1 2022Mar 31, 2022-$1.34M–
Q2 FY2022CQ4 2021Dec 31, 2021-$3.47M–
Q1 FY2022CQ3 2021Sep 30, 2021-$1.44M–
Q4 FY2021CQ2 2021Jun 30, 2021-$852.65K–
Q3 FY2021CQ1 2021Mar 31, 2021-$3.14M–
Q2 FY2021CQ4 2020Dec 31, 2020-$917.33K–
Q1 FY2021CQ3 2020Sep 30, 2020-$663.00K–
Q4 FY2020CQ2 2020Jun 30, 2020-$508.89K–
Q3 FY2020CQ1 2020Mar 31, 2020-$28.82K–
Q2 FY2020CQ4 2019Dec 31, 2019-$1.70M–

More Intelligent Bio Solutions figures

See a number that looks wrong?